Author Archives: admin
BioAtla’s Spin-Out Company, VivaMab, in the News
BioAtla’s Spin-Out Company, VivaMab, is part of a recent CPB Review feature story on biobetters and improved biologics. For a PDF download of the full article, please click on the article title below. Banking on a Big Biobetters Bonanza Will … Continue reading
Charles River and BioAtla announce partnership
–Companies collaborate to offer Integrated Biological Service for Preclinical Development– – SAN DIEGO, Calif. Charles River and BioAtla have recently partnered to create an integrated biological service for antibodies and other protein therapeutics designed to accelerate drug development for customers … Continue reading
BioAtla PDF Library
Learn more about the following topics by clicking to download a PDF: BioAtla’s Antibody Brochure BioAtla’s Protein Evolution Brochure Educational Topics: Antibody Isotypes Antibody Nomenclature Antibody Structure Clinical Process Scientific Glossary BioAtla Services: Affinity Maturation CIAO!™ Class Switch™ Express Humanization™ … Continue reading
Click here for BioAtla’s 2011 Calendar of Events
• June 27-30, 2011: Join us for the 2011 BIO International Convention, in Washington, DC at the Walter E. Washington Convention Center. • March 14-16, 2011: Join us for BIO-Europe Spring 2011, in Milan, Italy at the Milano Convention Center. – • Check back for … Continue reading
BioAtla Redefining the Business of Drug Discovery
– Company offers biotech firms new opportunities in wake of troubled global economy – SAN DIEGO, Calif., November 8, 2010. BioAtla, LLC, a San Diego-based protein therapeutics services provider, wants drug discovery companies worldwide to know one thing about operating … Continue reading
BioAtla introduces GigaMab™ Fully Human Antibody Platform
– New platform takes HuAb to the next level – SAN DIEGO, Calif., October 7, 2010. BioAtla, LLC, announced a new Fully Human Antibody Platform with full-length antibodies and over 10^9 members expressed in mammalian cells. This proprietary, expanded and … Continue reading
BIG launches a BioAtla sister company, Molecular Response
The BioAtla family is growing again! Our key investor, B.I.G. has announced the launch of a new therapeutics company, Molecular Response. A detailed release was recently issued and appears below: – Molecular Response launches west coast operations – San Diego, … Continue reading
BioWorld Today cites innovative BioAtla/Femta collaboration
– Industry publication recognizes our unique collaboration with Femta – An article appearing in the August 27, 2010 edition of BioWorld Today by Catherine Shaffer calls attention to the unique business partnership and shared technology platform between BioAtla (service provider) … Continue reading
Hello world!
Welcome to WordPress. This is your first post. Edit or delete it, then start blogging!
BioAtla inks 25th partnership, looks to continued growth
– Company that began in 2007 rapidly gains acceleration – SAN DIEGO, Calif., August 18, 2010. BioAtla, LLC, announced the signing of its 25th partnership with institutions that include private and public companies and venture capital groups and academia from … Continue reading
